Sean Yamada-Hunter

Title: Sean Yamada-Hunter: Innovator in Leukemia Research

Introduction

Sean Yamada-Hunter is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of cancer research, particularly in the development of innovative therapeutic approaches.

Latest Patents

Sean Yamada-Hunter holds a patent for "Soluble leukemia inhibitory factor receptor polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity." This patent includes soluble leukemia inhibitory factor receptor (LIFR) polypeptides, soluble glycoprotein 130 (gp130) polypeptides, and soluble fusion proteins and dimers that bind to leukemia inhibitory factor (LIF). The soluble polypeptides exhibit increased binding affinity for LIF compared to their wild-type counterparts. Additionally, the patent provides nucleic acids encoding these soluble polypeptides, expression vectors, and methods for using them to inhibit LIF activity in individuals, particularly for cancer treatment. He has 1 patent to his name.

Career Highlights

Sean Yamada-Hunter is affiliated with Leland Stanford Junior University, where he conducts his research and development work. His innovative approaches have the potential to significantly impact cancer therapies.

Collaborations

He collaborates with Jennifer R Cochran, contributing to advancements in their shared field of research.

Conclusion

Sean Yamada-Hunter is a dedicated inventor whose work in leukemia research exemplifies the importance of innovation in medical science. His contributions are paving the way for new therapeutic strategies in cancer treatment.